The Risk of Muscle Loss on GLP-1 Medications One of the unintended effects of weight loss on GLP-1s is the loss of not only fat but also lean muscle mass
G6PDH deficiency is the most common enzymopathy of RBCs [205], causing heterogeneous anemias, ranging from fauvism to acute or severe hemolytic anemias
For example, in a separate pooled analysis of 4 major clinical trials reporting cardiovascular events in patients with T2D and CKD, Kelly et al
SGLT2 inhibitors, commonly prescribed for type 2 diabetes, substantially increase the risk of genital mycotic infections due to their mechanism of increasing urinary glucose excretion
We understand that users who expected rapid weight loss often express frustration, while those who approached ColonBroom as a long-term support tool tended to report more satisfaction
however, additional complexity is likely involved [reviewed in (Hansen and Schedl, 2013)] 4.4.3 SCF PROM1 acts redundantly with the GLD-1 and GLD-2 pathways There is evidence of an additional pathway(s) that functions in parallel to the GLD-1 and GLD-2 pathways to inhibit proliferation and/or promote meiotic entry
